The effects of environmental chemicals on renal function

Nature Reviews Nephrology

Volumn 11, Issue 10, 2015, Pages 610-625

  Kataria, Anglina ^a   Trasande, Leonardo ^a   Trachtman, Howard ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; ALKYL GROUP; DIOXIN; ENVIRONMENTAL CHEMICAL; FURAN DERIVATIVE; PHTHALIC ACID; POLYCHLORINATED BIPHENYL; POLYCYCLIC AROMATIC HYDROCARBON; POLYFLUORINATED ALKYL ACID; UNCLASSIFIED DRUG; URIC ACID; BENZHYDRYL DERIVATIVE; FLUORINATED HYDROCARBON; PHENOL DERIVATIVE; PHTHALIC ACID DERIVATIVE; POLLUTANT; POLYCYCLIC HYDROCARBON;

ALBUMINURIA; BLOOD PRESSURE; CHRONIC KIDNEY DISEASE; DISEASE ASSOCIATION; ENVIRONMENTAL EXPOSURE; GENOMICS; GLOMERULUS FILTRATION RATE; HUMAN; INCIDENCE; KIDNEY FUNCTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEOMICS; REVIEW; RISK FACTOR; SOCIAL STATUS; URIC ACID BLOOD LEVEL; UTERUS; ADVERSE EFFECTS; CHEMICALLY INDUCED; DRUG EFFECTS; KIDNEY; KIDNEY DISEASE; PATHOPHYSIOLOGY; POLLUTANT;

ALBUMINURIA; BENZHYDRYL COMPOUNDS; BLOOD PRESSURE; DIOXINS; ENVIRONMENTAL POLLUTANTS; FURANS; HUMANS; HYDROCARBONS, FLUORINATED; KIDNEY; KIDNEY DISEASES; PHENOLS; PHTHALIC ACIDS; POLYCHLORINATED BIPHENYLS; POLYCYCLIC COMPOUNDS;

EID: 84941998212     PISSN: 17595061     EISSN: 1759507X     Source Type: Journal    
DOI: 10.1038/nrneph.2015.94     Document Type: Review

References (189)

1. Tchounwou, P. B., Yedjou, C. G., Patlolla, A. K. & Sutton, D. J. Heavy metal toxicity and the environment. EXS 101, 133-164 (2012
2. Malaguarnera, G. et al. Toxic hepatitis in occupational exposure to solvents. World J. Gastroenterol. 18, 2756-2766 (2012
3. Sathyanarayana, S. Phthalates and childrens health. Curr. Probl. Pediatr. Adolesc. Health Care 38, 34-49 (2008
4. Serrano, S. E., Braun, J., Trasande, L., Dills, R. & Sathyanarayana, S. Phthalates and diet: a review of the food monitoring and epidemiology data. Environ. Health 13, 43 (2014
5. Trasande, L. et al. Phthalates and the diets of US children and adolescents. Environ. Res. 126, 84-90 (2013
6. Hau, A. K., Kwan, T. H. & Li P. K. Melamine toxicity and the kidney. J. Am. Soc. Nephrol. 20, 245-250 (2009
7. Skinner, C. G., Thomas, J. D. & Osterloh, J. D. Melamine toxicity. J. Med. Toxicol. 6, 50-55 (2010
8. Gossner, C. M. et al. The melamine incident: implications for international food and feed safety. Environ. Health Perspect. 117, 1803-1808 (2009
9. Guan, N. et al. Melamine-contaminated powdered formula and urolithiasis in young children. N. Engl. J. Med. 360, 1067-1074 (2009
10. Yang, L. et al. Four years follow-up of 101 children with melamine-related urinary stones. Urolithiasis 41, 265-266 (2013
11. Liu, C. C. et al. Low exposure to melamine increases the risk of urolithiasis in adults. Kidney Int. 80, 746-752 (2011
12. Schettler, T. Human exposure to phthalates via consumer products. Int. J. Androl. 29, 134-139 (2006
13. Fromme, H. et al. Intake of phthalates and di(2-ethylhexyl)adipate: results of the Integrated Exposure Assessment Survey based on duplicate diet samples and biomonitoring data. Environ. Int. 33, 1012-1020 (2007
14. Tickner, J. A., Schettler, T., Guidotti, T., McCally, M. & Rossi, M. Health risks posed by use of di 2 ethylhexyl phthalate (DEHP) in PVC medical devices: a critical review. Am. J. Ind. Med. 39, 100-111 (2001
15. Sathyanarayana, S. et al. Unexpected results in a randomized dietary trial to reduce phthalate and bisphenol A exposures. J. Expo. Sci. Environ. Epidemiol. 23, 378-384 (2013
16. Rudel, R. A. et al. Food packaging and bisphenol A and bis(2-ethyhexyl) phthalate exposure: findings from a dietary intervention. Environ. Health Perspect. 119, 914-920 (2011
17. Su, P. H. et al. Exposure to di(2-ethylhexyl) phthalate in premature neonates in a neonatal intensive care unit in Taiwan. Pediatr. Crit. Care Med. 13, 671-677 (2012
18. Kambia, K. et al. Comparative study of the leachability of di(2-ethylhexyl) phthalate and tri(2-ethylhexyl) trimellitate from haemodialysis tubing. Int. J. Pharm. 229, 139-146 (2001
19. Faouzi, M. A. et al. Exposure of hemodialysis patients to di 2 ethylhexyl phthalate. Int. J. Pharm. 180, 113-121 (1999
20. Pollack, G. M., Buchanan, J. F., Slaughter, R. L., Kohli, R. K. & Shen, D. D. Circulating concentrations of di(2-ethylhexyl) phthalate and its de-esterified phthalic acid products following plasticizer exposure in patients receiving hemodialysis. Toxicol. Appl. Pharmacol. 79, 257-267 (1985
21. Wahl, H. G. et al. 4 Heptanone is a metabolite of the plasticizer di(2-ethylhexyl) phthalate (DEHP) in haemodialysis patients. Nephrol. Dial. Transplant. 19, 2576-2583 (2004
22. Nassberger, L., Arbin, A. & Ostelius, J. Exposure of patients to phthalates from polyvinyl chloride tubes and bags during dialysis. Nephron 45, 286-290 (1987
23. Frederiksen, H. et al. Human urinary excretion of non-persistent environmental chemicals: an overview of Danish data collected between 2006 and 2012. Reproduction 147, 555-565 (2014
24. Tremaine, L. M. & Quebbemann, A. J. The renal handling of terephthalic acid. Toxicol. Appl. Pharmacol. 77, 165-174 (1985
25. Frederiksen, H., Skakkebaek, N. E. & Andersson, A. M. Metabolism of phthalates in humans. Mol. Nutr. Food Res. 51, 899-911 (2007
26. Hauser, R., Meeker, J. D., Park, S., Silva, M. J. & Calafat, A. M. Temporal variability of urinary phthalate metabolite levels in men of reproductive age. Environ. Health Perspect. 112, 1734-1740 (2004
27. Hoppin, J. A., Brock, J. W., Davis, B. J. & Baird, D. D. Reproducibility of urinary phthalate metabolites in first morning urine samples. Environ. Health Perspect. 110, 515-518 (2002
28. Mes, J., Coffin, D. E. & Campbell, D. S. Di n butyl-and di 2 ethylhexyl phthalate in human adipose tissue. Bull. Environ. Contam. Toxicol. 12, 721-725 (1974
29. Trasande, L., Sathyanarayana, S. & Trachtman, H. Dietary phthalates and low-grade albuminuria in US children and adolescents. Clin. J. Am. Soc. Nephrol. 9, 100-109 (2014
30. Rais-Bahrami, K., Nunez, S., Revenis, M. E., Luban, N. L. & Short, B. L. Follow-up study of adolescents exposed to di(2-ethylhexyl) phthalate (DEHP) as neonates on extracorporeal membrane oxygenation (ECMO) support. Environ. Health Perspect. 112, 1339-1340 (2004
31. Trasande, L. et al. Urinary phthalates are associated with higher blood pressure in childhood. J. Pediatr. 163, 747-753.e1 (2013
32. Lind, P. M., Van Bavel, B., Salihovic, S. & Lind, L. Circulating levels of persistent organic pollutants (POPs) and carotid atherosclerosis in the elderly. Environ. Health Perspect. 120, 38-43 (2012
33. Posnack, N. G., Lee, N. H., Brown, R. & Sarvazyan, N. Gene expression profiling of DEHP-treated cardiomyocytes reveals potential causes of phthalate arrhythmogenicity. Toxicology 279, 54-64 (2011
34. Posnack, N. G., Swift, L. M., Kay, M. W., Lee, N. H. & Sarvazyan, N. Phthalate exposure changes the metabolic profile of cardiac muscle cells. Environ. Health Perspect. 120, 1243-1251 (2012
35. Olsen, L., Lind, L. & Lind, P. M. Associations between circulating levels of bisphenol A and phthalate metabolites and coronary risk in the elderly. Ecotoxicol. Environ. Saf. 80, 179-183 (2012
36. Olsen, L., Lampa, E., Birkholz, D. A., Lind, L. & Lind, P. M. Circulating levels of bisphenol A (BPA) and phthalates in an elderly population in Sweden, based on the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS). Ecotoxicol. Environ. Saf. 75, 242-248 (2012
37. Kanno, Y., Okada, H., Kobayashi, T., Takenaka, T. & Suzuki, H. Effects of endocrine disrupting substance on estrogen receptor gene transcription in dialysis patients. Ther. Apher. Dial. 11, 262-265 (2007
38. Shankar, A. & Teppala, S. Urinary bisphenol A and hypertension in a multiethnic sample of US adults. J. Environ. Public Health 2012, 481641 (2012
39. He, Y. et al. Bisphenol A levels in blood and urine in a Chinese population and the personal factors affecting the levels. Environ. Res. 109, 629-633 (2009
40. Nelson, J. W., Scammell, M. K., Hatch, E. E. & Webster, T. F. Social disparities in exposures to bisphenol A and polyfluoroalkyl chemicals: a cross-sectional study within NHANES 2003-2006. Environ. Health 11, 10 (2012
41. Murakami, K. et al. Accumulation of bisphenol A in hemodialysis patients. Blood Purif. 25, 290-294 (2007
42. Gayrard, V. et al. High bioavailability of bisphenol A from sublingual exposure. Environ. Health Perspect. 121, 951-956 (2013
43. Teeguarden, J. G. et al. 24-hour human urine and serum profiles of bisphenol A: evidence against sublingual absorption following ingestion in soup. Toxicol. Appl. Pharmacol. (2015
44. Fenichel, P., Chevalier, N. & Brucker-Davis, F. Bisphenol A: an endocrine and metabolic disruptor. Ann. Endocrinol. (Paris) 74, 211-220 (2013
45. Yang, X. & Fisher, J. W. Unraveling bisphenol A pharmacokinetics using physiologically based pharmacokinetic modeling. Front. Pharmacol. 5, 292 (2014
46. Sakamoto, H., Yokota, H., Kibe, R., Sayama, Y. & Yuasa, A. Excretion of bisphenol A glucuronide into the small intestine and deconjugation in the cecum of the rat. Biochim. Biophys. Acta. 1573, 171-176 (2002
47. Stahlhut, R. W., Welshons, W. V. & Swan, S. H. Bisphenol A data in NHANES suggest longer than expected half-life, substantial nonfood exposure, or both. Environ. Health Perspect. 117, 784-789 (2009
48. Koch, H. M., Kolossa-Gehring, M., Schroter-Kermani, C., Angerer, J. & Bruning, T. Bisphenol A in 24 h urine and plasma samples of the German Environmental Specimen Bank from 1995 to 2009: a retrospective exposure evaluation. J. Expo. Sci. Environ. Epidemiol. 22, 610-616 (2012
49. Kovacic, P. How safe is bisphenol A? Fundamentals of toxicity: metabolism, electron transfer and oxidative stress. Med. Hypotheses 75, 1-4 (2010
50. Li, M. et al. Exposure to bisphenol A is associated with low-grade albuminuria in Chinese adults. Kidney Int. 81, 1131-1139 (2012
51. Trasande, L., Attina, T. M. & Trachtman, H. Bisphenol A exposure is associated with low-grade urinary albumin excretion in children of the United States. Kidney Int. 83, 741-748 (2013
52. McGinley, E. L. Summary of: dental composite materials and renal function in children. Br. Dent. J. 216, 80-81 (2014
53. Trachtenberg, F. L., Shrader, P., Barregard, L. & Maserejian, N. N. Dental composite materials and renal function in children. Br. Dent. J. 216, E4 (2014
54. Olea-Herrero, N. et al. Bisphenol A induces podocytopathy with proteinuria in mice. J. Cell Physiol. (2014
55. You, L. et al. Renal function, bisphenol A, and alkylphenols: results from the National Health and Nutrition Examination Survey (NHANES 2003-2006). Environ. Health Perspect. 119, 527-533 (2011
56. Ahmadkhaniha, R. et al. Association of urinary bisphenol a concentration with type 2 diabetes mellitus. J. Environ. Health Sci. Eng. 12, 64 (2014
57. Bae, S., Kim, J. H., Lim, Y. H., Park, H. Y. & Hong, Y. C. Associations of bisphenol A exposure with heart rate variability and blood pressure. Hypertension 60, 786-793 (2012
58. Khalil, N. et al. Bisphenol A and cardiometabolic risk factors in obese children. Sci. Total Environ. 470-471, 726-32 (2014
59. Bae, S. & Hong, Y. C. Exposure to bisphenol A from drinking canned beverage increases blood pressure: randomized crossover trial. Hypertension 65, 313-319 (2015
60. Melzer, D. et al. Urinary bisphenol A concentration and risk of future coronary artery disease in apparently healthy men and women. Circulation 125, 1482-1490 (2012
61. Shankar, A., Teppala, S. & Sabanayagam, C. Bisphenol A and peripheral arterial disease: results from the NHANES. Environ. Health Perspect. 120, 1297-1300 (2012
62. LaKind, J. S., Goodman, M. & Naiman, D. Q. Use of NHANES data to link chemical exposures to chronic diseases: a cautionary tale. PLoS ONE 7, e51086 (2012
63. Lind, L. & Lind, P. M. Can persistent organic pollutants and plastic-associated chemicals cause cardiovascular disease? J. Intern. Med. 271, 537-553 (2012
64. Trudel, D. et al. Estimating Consumer Exposure to PFOS and PFOA. Risk Analysis 28, 251-269 (2008
65. Agency for Toxic Substances and Disease Registry (ATSDR). Toxicology Profiles [online], http://www.atsdr.cdc.gov/ (2015
66. Calafat, A. M., Wong, L. Y., Kuklenyik, Z., Reidy, J. A. & Needham, L. L. Polyfluoroalkyl chemicals in the US population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and Comparisons with NHANES 1999-2000. Environ. Health Perspect. 115, 1596-1602 (2007).
67. Ji, K. et al. Major perfluoroalkyl acid (PFAA) concentrations and influence of food consumption among the general population of Daegu, Korea. Sci. Total Environ. 438, 42-48 (2012
68. US Environmental Protection Agency. Long-chain perfluorinated chemicals (PFCs) action plan. [online] http://www.epa.gov/opptintr/existingchemicals/pubs/pfcs-action-plan1230-09.pdf (2009
69. Wen, L. L., Lin, L. Y., Su, T. C., Chen, P. C. & Lin, C. Y. Association between serum perfluorinated chemicals and thyroid function in U. S. adults: the National Health and Nutrition Examination Survey 2007-2010. J. Clin. Endocrinol. Metab. 98, E1456-E1464 (2013
70. Glynn, A. et al. Perfluorinated alkyl acids in blood serum from primiparous women in Sweden: serial sampling during pregnancy and nursing, and temporal trends 1996-2010. Environ. Sci. Technol. 46, 9071-9079 (2012
71. Perez, F. et al. Accumulation of perfluoroalkyl substances in human tissues. Environ. Int. 59, 354-362 (2013
72. Krafft, M. P. & Riess, J. G. Highly fluorinated amphiphiles and colloidal systems, and their applications in the biomedical field. A contribution. Biochimie 80, 489-514 (1998
73. Andersen, M. E. et al. Perfluoroalkyl acids and related chemistries-toxicokinetics and modes of action. Toxicol. Sci. 102, 3-14 (2008
74. Ohmori, K., Kudo, N., Katayama, K. & Kawashima, Y. Comparison of the toxicokinetics between perfluorocarboxylic acids with different carbon chain length. Toxicology 184, 135-140 (2003
75. Kudo, N. & Kawashima, Y. Toxicity and toxicokinetics of perfluorooctanoic acid in humans and animals. J. Toxicol. Sci. 28, 49-57 (2003
76. Seals, R., Bartell, S. M. & Steenland, K. Accumulation and clearance of perfluorooctanoic acid (PFOA) in current and former residents of an exposed community. Environ. Health Perspect. 119, 119-124 (2011
77. Olsen, G. W. et al. Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environ. Health Perspect. 115, 1298-1305 (2007
78. Shankar, A., Xiao, J. & Ducatman, A. Perfluoroalkyl chemicals and chronic kidney disease in US adults. Am. J. Epidemiol. 174, 893-900 (2011
79. Watkins, D. J. et al. Exposure to perfluoroalkyl acids and markers of kidney function among children and adolescents living near a chemical plant. Environ. Health Perspect. 121, 625-630 (2013
80. Cui, L., Zhou, Q. F., Liao, C. Y., Fu, J. J. & Jiang, G. B. Studies on the toxicological effects of PFOA and PFOS on rats using histological observation and chemical analysis. Arch. Environ. Contam. Toxicol. 56, 338-349 (2009
81. Geiger, S. D., Xiao, J. & Shankar, A. No association between perfluoroalkyl chemicals and hypertension in children. Integr. Blood Press. Control 7, 1-7 (2014
82. Shankar, A., Xiao, J. & Ducatman, A. Perfluoroalkyl chemicals and elevated serum uric acid in US adults. Clin. Epidemiol. 3, 251-258 (2011
83. Geiger, S. D., Xiao, J. & Shankar, A. Positive association between perfluoroalkyl chemicals and hyperuricemia in children. Am. J. Epidemiol. 177, 1255-1262 (2013
84. US Environmental Protection Agency. EPAs reanalysis of key issues related to dioxin toxicity and response to NAS comments, volume 1. [online] http://www.epa.gov/iris/supdocs/dioxinv1sup.pdf (2012
85. Milbrath, M. O. G. et al. Apparent half-lives of dioxins, furans, and polychlorinated biphenyls as a function of age, body fat, smoking status, and breast-feeding. Environ. Health Perspect. 117, 417-425 (2009
86. International Agency for Research on Cancer. Chemical agents and related occupations: 2, 3, 7, 8 tetrachlorodibenzo- para-dioxin, 2, 3, 4, 7, 8-pentachlorodibenzofuran, and 3, 3, 4, 45-pentachlorobiphenyl. IARC Monogr. Eval. Carcinog. Risks Hum. 100F, 339-378 (2012
87. Rocas, M., Jakubauskiene, E. & Kanopka, A. Polymorphism of the aryl-hydrocarbon receptor gene in intron 10 of human cancers. Braz. J. Med. Biol. Res. 44, 1112-1117 (2011
88. Heid, S. E., Walker, M. K. & Swanson, H. I. Correlation of cardiotoxicity mediated by halogenated aromatic hydrocarbons to aryl hydrocarbon receptor activation. Toxicol. Sci. 61, 187-196 (2001
89. McGee, S. P., Konstantinov, A., Stapleton, H. M. & Volz, D. C. Aryl phosphate esters within a major pentaBDE replacement product induce cardiotoxicity in developing zebrafish embryos: potential role of the aryl hydrocarbon receptor. Toxicol. Sci. 133, 144-156 (2013
90. Van Ede, K. I., Gaisch, K. P., Van den Berg, M. & Van Duursen, M. B. Differential relative effect potencies of some dioxin-like compounds in human peripheral blood lymphocytes and murine splenic cells. Toxicol. Lett. 226, 43-52 (2014
91. Kitamura, K. et al. Dioxins in bile in relation to those in the human liver and blood. J. Toxicol. Sci. 26, 327-336 (2001
92. Antkiewicz, D. S., Peterson, R. E. & Heideman, W. Blocking expression of AHR2 and ARNT1 in zebrafish larvae protects against cardiac toxicity of 2, 3, 7, 8 tetrachlorodibenzo p-dioxin. Toxicol. Sci. 94, 175-182 (2006
93. Everett, C. J. & Thompson, O. M. Dioxins, furans and dioxin-like PCBs in human blood: causes or consequences of diabetic nephropathy? Environ. Res. 132, 126-131 (2014
94. Chang, J. W., Ou, H. Y., Chen, H. L., Su, H. J. & Lee, C. C. Hyperuricemia after exposure to polychlorinated dibenzo p dioxins and dibenzofurans near a highly contaminated area. Epidemiology 24, 582-589 (2013
95. Ha, M. H., Lee, D. H., Son, H. K., Park, S. K. & Jacobs, D. R. Jr. Association between serum concentrations of persistent organic pollutants and prevalence of newly diagnosed hypertension: results from the National Health and Nutrition Examination Survey 1999-2002. J. Hum. Hypertens. 23, 274-286 (2009
96. Chang, J. W. et al. Interrelationship between exposure to PCDD/Fs and hypertension in metabolic syndrome in Taiwanese living near a highly contaminated area. Chemosphere 81, 1027-1032 (2010
97. Karouna-Renier, N. K., Rao, K. R., Lanza, J. J., Davis, D. A. & Wilson, P. A. Serum profiles of PCDDs and PCDFs, in individuals near the Escambia Wood Treating Company Superfund site in Pensacola, FL. Chemosphere 69, 1312-1319 (2007
98. Lee, D. H., Lee, I. K., Porta, M., Steffes, M. & Jacobs, D. R. Jr. Relationship between serum concentrations of persistent organic pollutants and the prevalence of metabolic syndrome among non-diabetic adults: results from the National Health and Nutrition Examination Survey 1999-2002. Diabetologia 50, 1841-1851 (2007
99. Nakamoto, M. et al. Association between blood levels of PCDDs/PCDFs/dioxin-like PCBs and history of allergic and other diseases in the Japanese population. Int. Arch. Occup. Environ. Health 86, 849-859 (2013
100. Uemura, H. et al. Prevalence of metabolic syndrome associated with body burden levels of dioxin and related compounds among Japans general population. Environ. Health Perspect. 117, 568-573 (2009
101. Kitamura, K. et al. Health effects of chronic exposure to polychlorinated dibenzo P dioxins (PCDD), dibenzofurans (PCDF) and coplanar PCB (Co-PCB) of municipal waste incinerator workers. J. Epidemiol. 10, 262-270 (2000
102. Lee, Y. M., Bae, S. G., Lee, S. H., Jacobs, D. R. Jr & Lee, D. H. Persistent organic pollutants and hyperuricemia in the U.S. general population. Atherosclerosis 230, 1-5 (2013
103. Agency for Toxic Substances and Disease Registry. Public Health Statement: polycyclic aromatic hydrocarbons (PAHs) [online] http://www.atsdr.cdc.gov/toxprofiles/tp69.pdf (1995
104. Fang, G. C., Wu, Y. S., Fu, P. P., Yang, I. L. & Chen, M. H. Polycyclic aromatic hydrocarbons in the ambient air of suburban and industrial regions of central Taiwan. Chemosphere 54, 443-452 (2004
105. Harvey, R. G., Dai, Q., Ran, C. & Penning, T. M. Synthesis of the o quinones and other oxidized metabolites of polycyclic aromatic hydrocarbons implicated in carcinogenesis. J. Org. Chem. 69, 2024-2032 (2004
106. Garcia-Canton, C., Anadon, A. & Meredith, C. Genotoxicity evaluation of individual cigarette smoke toxicants using the in vitro gammaH2AX assay by high content screening. Toxicol. Lett. 223, 81-7 (2013
107. Tonne, C. C., Whyatt, R. M., Camann, D. E., Perera, F. P. & Kinney, P. L. Predictors of personal polycyclic aromatic hydrocarbon exposures among pregnant minority women in New York City. Environ. Health Perspect. 112, 754-759 (2004
108. Jung, K. H. et al. Time trends of polycyclic aromatic hydrocarbon exposure in New York City from 2001 to 2012: assessed by repeat air and urine samples. Environ. Res. 131, 95-103 (2014
109. Sultana, S. et al. Association of CYP1A1 Gene Polymorphism with Ischemic Stroke in South Indian Population. Trans. Stroke Res. 2, 26-32 (2011
110. Nerurkar, P. V. et al. CYP1A1, GSTM1, and GSTP1 genetic polymorphisms and urinary 1 hydroxypyrene excretion in non-occupationally exposed individuals. Cancer Epidemiol. Biomarkers Prev. 9, 1119-1122 (2000
111. Tas, S., Buchet, J. P. & Lauwerys, R. Determinants of benzo[a]pyrene diol epoxide adducts to albumin in workers exposed to polycyclic aromatic hydrocarbons. Int. Archives Occup. Environ. Health 66, 343-348 (1994
112. Tuominen, R. et al. Susceptibility factors and DNA adducts in peripheral blood mononuclear cells of aluminium smelter workers exposed to polycyclic aromatic hydrocarbons. Arch. Toxicol. 76, 178-186 (2002
113. Everett, C. J. et al. Association of urinary polycyclic aromatic hydrocarbons and serum C reactive protein. Environ. Res. 110, 79-82 (2010
114. Hansson, G. K., Robertson, A. K. & Soderberg-Naucler, C. Inflammation and atherosclerosis. Annu. Rev. Pathol. 1, 297-329 (2006
115. Voice, T. C. et al. Evaluation of the hypothesis that Balkan endemic nephropathy is caused by drinking water exposure to contaminants leaching from Pliocene coal deposits. J. Expo. Sci. Environ. Epidemiol. 16, 515-524 (2006
116. Stefanovic, V. Balkan endemic nephropathy: a need for novel aetiological approaches. QJM 91, 457-463 (1998
117. Stefanovic, V., Cukuranovic, R., Miljkovic, S., Marinkovic, D. & Toncheva, D. Fifty years of Balkan endemic nephropathy: challenges of study using epidemiological method. Ren. Fail. 31, 409-418 (2009
118. Stefanovic, V., Toncheva, D., Atanasova, S. & Polenakovic, M. Etiology of Balkan endemic nephropathy and associated urothelial cancer. Am. J. Nephrol. 26, 1-11 (2006
119. Jacobs, L. et al. Acute changes in pulse pressure in relation to constituents of particulate air pollution in elderly persons. Environ. Res. 117, 60-67 (2012
120. McFarland, V. A. & Clarke, J. U. Environmental occurrence, abundance, and potential toxicity of polychlorinated biphenyl congeners: considerations for a congener-specific analysis. Environ. Health Perspect. 81, 225-239 (1989
121. Sjodin, A. et al. Polybrominated diphenyl ethers, polychlorinated biphenyls, and persistent pesticides in serum from the national health and nutrition examination survey: 2003-2008. Environ. Sci. Technol. 48, 753-60 (2014
122. Kreiss, K. Studies on populations exposed to polychlorinated biphenyls. Environ. Health Perspect. 60, 193-199 (1985
123. Kreiss, K. et al. Association of blood pressure and polychlorinated biphenyl levels. JAMA 245, 2505-2509 (1981
124. Agency for Toxic Substances and Disease Registry. Toxicological Profile for Polychlorinated Biphenyls (PCBs) [online] http://www.atsdr.cdc.gov/toxfaqs/tfacts17.pdf (2000
125. Megson, D. et al. Elucidating the structural properties that influence the persistence of PCBs in humans using the National Health and Nutrition Examination Survey (NHANES) dataset. Sci. Total Environ. 461-462, 99-107 (2013
126. Ludewig, G., Lehmann, L., Esch, H. & Robertson, L. W. Metabolic activation of PCBs to carcinogens in vivo - A review. Environ. Toxicol. Pharmacol. 25, 241-246 (2008
127. Baker, E. L. Jr. et al. Metabolic consequences of exposure to polychlorinated biphenyls (PCB) in sewage sludge. Am. J. Epidemiol. 112, 553-563 (1980
128. Goncharov, A., Bloom, M., Pavuk, M., Birman, I. & Carpenter, D. O. Blood pressure and hypertension in relation to levels of serum polychlorinated biphenyls in residents of Anniston, Alabama. J. Hypertens. 28, 2053-2060 (2010
129. Goncharov, A., Pavuk, M., Foushee, H. R. & Carpenter, D. O. Blood pressure in relation to concentrations of PCB congeners and chlorinated pesticides. Environ. Health Perspect. 119, 319-325 (2011
130. Everett, C. J., Mainous, A. G. 3rd, Frithsen, I. L., Player, M. S. & Matheson, E. M. Commentary on the association of polychlorinated biphenyls with hypertension. Environ. Res. 108, 428-429 (2008
131. Yorita Christensen, K. L. & White, P. A methodological approach to assessing the health impact of environmental chemical mixtures: PCBs and hypertension in the National Health and Nutrition Examination Survey. Int. J. Environ. Res. Public Health 8, 4220-4237 (2011
132. Lind, P. M., Penell, J., Salihovic, S., Van Bavel, B. & Lind, L. Circulating levels of p, p'-DDE are related to prevalent hypertension in the elderly. Environ. Res. 129, 27-31 (2014
133. Sjoberg Lind, Y., Lind, P. M., Salihovic, S., Van Bavel, B. & Lind, L. Circulating levels of persistent organic pollutants (POPs) are associated with left ventricular systolic and diastolic dysfunction in the elderly. Environ. Res. 123, 39-45 (2013
134. Peters, J. L., Patricia Fabian, M. & Levy, J. I. Combined impact of lead, cadmium, polychlorinated biphenyls and non-chemical risk factors on blood pressure in NHANES. Environ. Res. 132c, 93-99 (2014
135. Valera, B., Ayotte, P., Poirier, P. & Dewailly, E. Associations between plasma persistent organic pollutant levels and blood pressure in Inuit adults from Nunavik. Environ. Int. 59, 282-289 (2013
136. Valera, B., Jorgensen, M. E., Jeppesen, C. & Bjerregaard, P. Exposure to persistent organic pollutants and risk of hypertension among Inuit from Greenland. Environ. Res. 122, 65-73 (2013
137. Imamura, T. et al. Cutaneous symptoms such as acneform eruption and pigmentation are closely associated with blood levels of 2, 3, 4, 7, 8 penta chlorodibenzofurans in Yusho patients, using data mining analysis. BMC Res. Notes 2, 27 (2009
138. Correa-Rotter, R., Wesseling, C. & Johnson, R. J. CKD of unknown origin in Central America: the case for a Mesoamerican nephropathy. Am. J. Kidney Dis. 63, 506-520 (2014
139. Weiner, D. E., McClean, M. D., Kaufman, J. S. & Brooks, D. R. The Central American epidemic of CKD. Clin. J. Am. Soc. Nephrol. 8, 504-511 (2013
140. Nanayakkara, S. et al. Tubulointerstitial damage as the major pathological lesion in endemic chronic kidney disease among farmers in North Central Province of Sri Lanka. Environ. Health Prev. Med. 17, 213-221 (2012
141. Jayasumana, C., Gajanayake, R. & Siribaddana, S. Importance of arsenic and pesticides in epidemic chronic kidney disease in Sri Lanka. BMC Nephrol. 15, 124 (2014
142. Jayatilake, N., Mendis, S., Maheepala, P. & Mehta, F. R. Chronic kidney disease of uncertain aetiology: prevalence and causative factors in a developing country. BMC Nephrol. 14, 180 (2013
143. Johnson, R. J. et al. Hyperosmolarity drives hypertension and CKD-water and salt revisited. Nat. Rev. Nephrol. 10, 415-420 (2014
144. Ordunez, P. et al. Chronic kidney disease epidemic in Central America: urgent public health action is needed amid causal uncertainty. PLoS Negl. Trop. Dis. 8, e3019 (2014
145. Ehrlich, S., Calafat, A M., Humblet, O., Smith, T. & Hauser, R. Handling of thermal receipts as a source of exposure to bisphenol A. JAMA 311, 859-860 (2014
146. Ramirez-Sandoval, J. C. et al. Urinary neutrophil gelatinase-associated lipocalin predicts graft loss after acute kidney injury in kidney transplant. Biomarkers 19, 63-69 (2014
147. Gluhovschi, G. et al. Familial versus environmental factors in Balkan endemic nephropathy in Mehedinti county, Romania, by means of albuminuria and tubular biomarkers: preliminary study. Ren. Fail. 37, 219-224 (2015
148. Pickering, J. W. & Endre, Z. H. Acute kidney injury urinary biomarker time-courses. PLoS One 9, e101288 (2014
149. Sabbisetti, V. S. et al. Blood kidney injury molecule 1 is a biomarker of acute and chronic kidney injury and predicts progression to ESRD in type I diabetes. J. Am. Soc. Nephrol. 25, 2177-2186 (2014
150. Weaver, V. M., Kotchmar, D. J., Fadrowski, J. J. & Silbergeld, E. K. Challenges for environmental epidemiology research: are biomarker concentrations altered by kidney function or urine concentration adjustment? J. Expo. Sci. Environ. Epidemiol. http://dx.doi.org/10.1038/jes.2015.8.
151. Suliman, M. et al. The reverse epidemiology of plasma total homocysteine as a mortality risk factor is related to the impact of wasting and inflammation. Nephrol. Dial. Transplant. 22, 209-217 (2007
152. Alberti, K. G. M. M. et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120, 1640-1645 (2009
153. Singh, U. & Jialal, I. Oxidative stress and atherosclerosis. Pathophysiology 13, 129-142 (2006
154. Harrison, D., Griendling, K. K., Landmesser, U., Hornig, B. & Drexler, H. Role of oxidative stress in atherosclerosis. Am. J. Cardiol. 91, 7-11 (2003
155. Marshall, C. B., Pippin, J. W., Krofft, R. D. & Shankland, S. J. Puromycin aminonucleoside induces oxidant-dependent DNA damage in podocytes in vitro and in vivo. Kidney Int. 70, 1962-1973 (2006
156. Piwkowska, A., Rogacka, D., Jankowski, M., Kocbuch, K. & Angielski, S. Hydrogen peroxide induces dimerization of protein kinase G type Ia subunits and increases albumin permeability in cultured rat podocytes. J. Cell. Physiol. 227, 1004-1016 (2012
157. Barisoni, L., Schnaper, H. W. & Kopp, J. B. A proposed taxonomy for the podocytopathies: a reassessment of the primary nephrotic diseases. Clin. J. Am. Soc. Nephrol. 2, 529-542 (2007
158. Nath, K. A. Tubulointerstitial changes as a major determinant in the progression of renal damage. Am. J. Kidney Dis. 20, 1-17 (1992
159. Everett, C. J., Mainous, A. G. 3rd, Frithsen, I. L., Player, M. S. & Matheson, E. M. Association of polychlorinated biphenyls with hypertension in the 1999-2002 National Health and Nutrition Examination Survey. Environ. Res. 108, 94-97 (2008
160. US Environmental Protection Agency. Bisphenol A (BPA) action plan summary. [online] http://www.epa.gov/opptintr/existingchemicals/pubs/actionplans/bpa.html (2013
161. Hasselberg, L., Meier, S. & Svardal, A. Effects of alkylphenols on redox status in first spawning Atlantic cod (Gadus morhua). Aquat. Toxicol. 69, 95-105 (2004
162. Atkinson, A. & Roy, D. In vivo DNA adduct formation by bisphenol A. Environ. Mol. Mutag. 26, 60-66 (1995
163. Hugo, E. R. et al. Bisphenol A at environmentally relevant doses inhibits adiponectin release from human adipose tissue explants and adipocytes. Environ. Health Perspect. 116, 1642-1647 (2008
164. Jepsen, K. F., Abildtrup, A. & Larsen, S. T. Monophthalates promote IL 6 and IL 8 production in the human epithelial cell line A549. Toxicol. In Vitro 18, 265-269 (2004
165. Gourlay, T., Samartzis, I., Stefanou, D. & Taylor, K. Inflammatory response of rat and human neutrophils exposed to di (2 ethyl hexyl) phthalate plasticized polyvinyl chloride. Artif. Organs 27, 256-260 (2003
166. Ferguson, K. K., Loch-Caruso, R. & Meeker, J. D. Urinary phthalate metabolites in relation to biomarkers of inflammation and oxidative stress: NHANES 1999-2006. Environ. Res. 111, 718-726 (2011
167. Sowers, J. R., Whaley-Connell, A. & Hayden, M.R. The role of overweight and obesity in the cardiorenal syndrome. Cardiorenal Med. 1, 5-12 (2011
168. Qian, Y. et al. Perfluorooctane sulfonate (PFOS) induces reactive oxygen species (ROS) production in human microvascular endothelial cells: role in endothelial permeability. J. Toxicol. Environ. Res. Health 73, 819-836 (2010
169. Sutton, T. A. et al. Injury of the renal microvascular endothelium alters barrier function after ischemia. Am. J. Physiol. Renal Physiol. 285, F191-F198 (2003
170. Albina, M. L. et al. Effects of exposure to BDE 99 on oxidative status of liver and kidney in adult rats. Toxicology 271, 51-56 (2010
171. Araujo, J. A., Barajas, B., Kleinman, M. et al. Ambient particulate pollutants in the ultrafine range promote early atherosclerosis and systemic oxidative stress. Circ. Res. 102, 589-596 (2008
172. Chuang, H. C., Fan, C. W., Chen K. Y., Chang-Chien, G. P. & Chan, C. C. Vasoactive alteration and inflammation induced by polycyclic aromatic hydrocarbons and trace metals of vehicle exhaust particles. Toxicol. Lett. 214, 131-136 (2012
173. Singh, U. & Jialal, I. Oxidative stress and atherosclerosis. Pathophysiology 13, 129-142 (2006
174. Harrison, D., Griendling, K. K., Landmesser, U., Hornig, B. & Drexler H. Role of oxidative stress in atherosclerosis. Am. J. Cardiol. 91, 7-11 (2003
175. Barker, D. J., Godfrey, K. M., Osmond, C. & Bull, A. The relation of fetal length, ponderal index and head circumference to blood pressure and the risk of hypertension in adult life. Paediatr. Perinat. Epidemiol. 6, 35-44 (1992
176. Barker, D. J., Osmond, C., Forsen, T. J., Kajantie, E. & Eriksson, J. G. Trajectories of growth among children who have coronary events as adults. N. Engl. J. Med. 353, 1802-1809 (2005
177. Barker, D. J. The fetal and infant origins of adult disease. BMJ 301, 1111 (1990
178. Barker, D. J. & Osmond, C. Infant mortality, childhood nutrition, and ischaemic heart disease in England and Wales. Lancet 1, 1077-1081 (1986
179. Zhang, Y. et al. Phthalate levels and low birth weight: a nested case-control study of chinese newborns. J. Pediatr. 155, 500-504 (2009
180. Snijder, C. A. et al. Fetal growth and prenatal exposure to bisphenol A: the generation R study. Environ. Health Perspect. 121, 393-398 (2013
181. Gascon, M. et al. Prenatal exposure to bisphenol A and phthalates and childhood respiratory tract infections and allergy. J. Allergy Clin. Immunol. (2014
182. Whyatt, R. M. et al. Maternal prenatal urinary phthalate metabolite concentrations and child mental, psychomotor, and behavioral development at 3 years of age. Environ. Health Perspect. 120, 290-295 (2012
183. Perera, F. P. et al. Prenatal polycyclic aromatic hydrocarbon (PAH) exposure and child behavior at age 6-7 years. Environ. Health Perspect. 120, 921-926 (2012
184. Olsen, G. W., Butenhoff, J. L. & Zobel, L. R. Perfluoroalkyl chemicals and human fetal development: an epidemiologic review with clinical and toxicological perspectives. Reprod. Toxicol. 27, 212-230 (2009
185. Schmieder, R. E. et al. Low-grade albuminuria and cardiovascular risk: what is the evidence? Clin. Res. Cardiol. 96, 247-257 (2007
186. DeBosch, B. J., Kluth, O., Fujiwara, H., Schurmann, A. & Moley, K. Early-onset metabolic syndrome in mice lacking the intestinal uric acid transporter SLC2A9. Nat. Commun. 5, 4642 (2014
187. Trasande, L. & Liu, Y. Reducing the staggering costs of environmental disease in children, estimated at $76.6 billion in 2008. Health Aff. (Millwood) 30, 863-70 (2011
188. Trasande, L. et al. How developing nations can protect children from hazardous chemical exposures while sustaining economic growth. Health Aff. (Millwood) 30, 2400-2409 (2011
189. Trasande, L. Further limiting bisphenol a in food uses could provide health and economic benefits. Health Aff. (Millwood) 33, 316-323 (2014